dupilumab

Ligand id: 7574

Name: dupilumab

References
1. Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, Hellings P, Jiao L, Wang L, Evans RR et al.. (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
JAMA315 (5): 469-79. [PMID:26836729]
2. Martin JH, Huang TT, Fairhurst JL, Papadopoulos NJ. (2009)
Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders.
Patent number: US7608693. Assignee: Regeneron Pharmaceuticals, Inc.. Priority date: 02/10/2006. Publication date: 27/10/2009.
3. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B et al.. (2013)
Dupilumab in persistent asthma with elevated eosinophil levels.
N. Engl. J. Med.368 (26): 2455-66. [PMID:23688323]